OBJECTIVE Gamma Knife radiosurgery (GKRS) is frequently used to treat residual or recurrent nonfunctioning pituitary macroadenomas. There is no consensus as to whether GKRS should be used early after surgery or if radiosurgery should be withheld until there is evidence of imaging-defined progression of tumor. Given the high incidence of adenoma progression after subtotal resection over time, the present study intended to evaluate the effect of timing of radiosurgery on outcome. METHODS This is a multicenter retrospective review of patients with nonfunctioning pituitary macroadenomas who underwent transsphenoidal surgery followed by GKRS from 1987 to 2015 at 9 institutions affiliated with the International Gamma Knife Research Foundation. Patients were matched by adenoma and radiosurgical parameters and stratified based on the interval between last resection and radiosurgery. Operative results, imaging data, and clinical outcomes were compared across groups following early (≤ 6 months after resection) or late (> 6 months after resection) radiosurgery. RESULTS After matching, 222 patients met the authors' study criteria (from an initial collection of 496 patients) and were grouped based on early (n = 111) or late (n = 111) GKRS following transsphenoidal surgery. There was a greater risk of tumor progression after GKRS (p = 0.013) and residual tumor (p = 0.038) in the late radiosurgical group over a median imaging follow-up period of 68.5 months. No significant difference in the occurrence of post-GKRS endocrinopathy was observed (p = 0.68). Thirty percent of patients without endocrinopathy in the early cohort developed new endocrinopathies during the follow-up period versus 27% in the late cohort (p = 0.84). Fourteen percent of the patients in the early group and 25% of the patients in the late group experienced the resolution of endocrine dysfunction after original presentation (p = 0.32). CONCLUSIONS In this study, early GKRS was associated with a lower risk of radiological progression of subtotally resected nonfunctioning pituitary macroadenomas compared with expectant management followed by late radiosurgery. Delaying radiosurgery may increase patient risk for long-term adenoma progression. The timing of radiosurgery does not appear to significantly affect the rate of delayed endocrinopathy.

Cleveland Clinic Foundation Center for Neurological Restoration Cleveland Ohio

Department of Neurosurgery Centre Hospitalier Universitaire de Sherbrooke Quebec Canada

Department of Neurosurgery NYU Langone Medical Center New York New York

Department of Neurosurgery Taipei Veterans General Hospital Taipei City Taiwan

Department of Neurosurgery University of Pittsburgh Medical Center Pittsburgh Pennsylvania; and

Department of Neurosurgery University of Virginia Health System Charlottesville Virginia

Department of Neurosurgery West Virginia University Medical Center Morgantown West Virginia

Department of Radiation Oncology William Beaumont Hospital Royal Oak Michigan

Department of Stereotactic and Radiation Neurosurgery Na Homolce Hospital Prague Czech Republic

Zobrazit více v PubMed

Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, et al. Gamma-Knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab. 2003;88:3105–3112. PubMed

Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S, et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 1993;38:571–578. PubMed

Brochier S, Galland F, Kujas M, Parker F, Gaillard S, Raftopoulos C, et al. Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. Eur J Endocrinol. 2010;163:193–200. PubMed

Castro DG, Cecílio SA, Canteras MM. Radiosurgery for pituitary adenomas: evaluation of its efficacy and safety. Radiat Oncol. 2010;5:109. PubMed PMC

Chandler WF, Schteingart DE, Lloyd RV, McKeever PE, Ibarra-Perez G. Surgical treatment of Cushing’s disease. J Neurosurg. 1987;66:204–212. PubMed

Chang EF, Zada G, Kim S, Lamborn KR, Quinones-Hinojosa A, Tyrrell JB, et al. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J Neurosurg. 2008;108:736–745. PubMed

Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J. The clinical and endocrine outcome to transsphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer. 1991;68:860–866. PubMed

Dallapiazza RF, Grober Y, Starke RM, Laws ER, Jr, Jane JA., Jr Long-term results of endonasal endoscopic transsphenoidal resection of nonfunctioning pituitary macroadenomas. Neurosurgery. 2015;76:42–53. PubMed

Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab. 2006;91:4769–4775. PubMed

Dekkers OM, Pereira AM, Roelfsema F, Voormolen JH, Neelis KJ, Schroijen MA, et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab. 2006;91:1796–1801. PubMed

Dekkers OM, Pereira AM, Romijn JA. Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab. 2008;93:3717–3726. PubMed

Ebersold MJ, Laws ER, Jr, Scheithauer BW, Randall RV. Pituitary apoplexy treated by transsphenoidal surgery. A clinicopathological and immunocytochemical study. J Neurosurg. 1983;58:315–320. PubMed

El-Shehaby AM, Reda WA, Tawadros SR, Abdel Karim KM. Low-dose Gamma Knife surgery for nonfunctioning pituitary adenomas. J Neurosurg. 2012;117(Suppl):84–88. PubMed

Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, et al. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004;101:613–619. PubMed

Feigl GC, Pistracher K, Berghold A, Mokry M. Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas: the role of the hypothalamus. J Neurosurg. 2010;113(Suppl):153–159. PubMed

Fernández-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, et al. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2011;96:905–912. PubMed

Ferrante E, Ferraroni M, Castrignanò T, Menicatti L, Anagni M, Reimondo G, et al. Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol. 2006;155:823–829. PubMed

Gopalan R, Schlesinger D, Vance ML, Laws E, Sheehan J. Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma. Neurosurgery. 2011;69:284–293. PubMed

Greenman Y, Ouaknine G, Veshchev I, Reider-Groswasser II, Segev Y, Stern N. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol (Oxf) 2003;58:763–769. PubMed

Greenman Y, Stern N. How should a nonfunctioning pituitary macroadenoma be monitored after debulking surgery? Clin Endocrinol (Oxf) 2009;70:829–832. PubMed

Hayashi M, Chernov M, Tamura N, Nagai M, Yomo S, Ochiai T, et al. Gamma Knife robotic microradiosurgery of pituitary adenomas invading the cavernous sinus: treatment concept and results in 89 cases. J Neurooncol. 2010;98:185–194. PubMed

Höybye C, Rähn T. Adjuvant Gamma Knife radiosurgery in non-functioning pituitary adenomas; low risk of long-term complications in selected patients. Pituitary. 2009;12:211–216. PubMed

Iwai Y, Yamanaka K, Yoshioka K. Radiosurgery for nonfunctioning pituitary adenomas. Neurosurgery. 2005;56:699–705. PubMed

Iwata H, Sato K, Tatewaki K, Yokota N, Inoue M, Baba Y, et al. Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity. Neuro Oncol. 2011;13:916–922. PubMed PMC

Kajiwara K, Saito K, Yoshikawa K, Kato S, Akimura T, Nomura S, et al. Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas. Minim Invasive Neurosurg. 2005;48:91–96. PubMed

Kobayashi T. Long-term results of stereotactic Gamma Knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma. Prog Neurol Surg. 2009;22:77–95. PubMed

Langsenlehner T, Stiegler C, Quehenberger F, Feigl GC, Jakse G, Mokry M, et al. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome. Strahlenther Onkol. 2007;183:241–247. PubMed

Laws ER, Jr, Ebersold MJ, Piepgras DG, Randall RV, Salassa RM. The results of transsphenoidal surgery in specific clinical entities. In: Laws ER JR, Randall RV, Kern EB, et al., editors. Management of Pituitary Adenomas and Related Lesions with Emphasis on Transsphenoidal Microsurgery. New York: Appleton-Century-Crofts; 1982. pp. 277–305.

Laws ER, Jr, Vance ML. Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin N Am. 1999;10:327–336. PubMed

Liscák R, Vladyka V, Marek J, Simonová G, Vymazal J. Gamma Knife radiosurgery for endocrine-inactive pituitary adenomas. Acta Neurochir (Wien) 2007;149:999–1006. PubMed

Losa M, Mortini P, Barzaghi R, Ribotto P, Terreni MR, Marzoli SB, et al. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg. 2008;108:525–532. PubMed

Losa M, Valle M, Mortini P, Franzin A, da Passano CF, Cenzato M, et al. Gamma Knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. J Neurosurg. 2004;100:438–444. PubMed

Mak HK, Lai SW, Qian W, Xu S, Tong E, Vance ML, et al. Effective time window in reducing pituitary adenoma size by Gamma Knife radiosurgery. Pituitary. 2015;18:509–517. PubMed

Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER., Jr The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg. 2002;96:195–208. PubMed

Mingione V, Yen CP, Vance ML, Steiner M, Sheehan J, Laws ER, et al. Gamma surgery in the treatment of nonsecretory pituitary macroadenoma. J Neurosurg. 2006;104:876–883. PubMed

Minniti G, Gilbert DC, Brada M. Modern techniques for pituitary radiotherapy. Rev Endocr Metab Disord. 2009;10:135–144. PubMed

Minniti G, Jaffrain-Rea ML, Osti M, Cantore G, Enrici RM. Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques. Neurosurg Rev. 2007;30:167–176. PubMed

Minniti G, Scaringi C, Poggi M, Jaffrain Rea ML, Trillò G, Esposito V, et al. Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor response. Eur J Endocrinol. 2015;172:433–441. PubMed

Muacevic A, Uhl E, Wowra B. Gamma knife radiosurgery for nonfunctioning pituitary adenomas. Acta Neurochir Suppl. 2004;91:51–54. PubMed

Oldfield EH. Editorial. Management of invasion by pituitary adenomas. J Neurosurg. 2014;121:501–503. PubMed

O’Sullivan EP, Woods C, Glynn N, Behan LA, Crowley R, O’Kelly P, et al. The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf) 2009;71:709–714. PubMed

Park KJ, Kano H, Parry PV, Niranjan A, Flickinger JC, Lunsford LD, et al. Long-term outcomes after Gamma Knife stereotactic radiosurgery for nonfunctional pituitary adenomas. Neurosurgery. 2011;69:1188–1199. PubMed

Park P, Chandler WF, Barkan AL, Orrego JJ, Cowan JA, Griffith KA, et al. The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery. 2004;55:100–107. PubMed

Petrovich Z, Yu C, Giannotta SL, Zee CS, Apuzzo ML. Gamma Knife radiosurgery for pituitary adenoma: early results. Neurosurgery. 2003;53:51–61. PubMed

Picozzi P, Losa M, Mortini P, Valle MA, Franzin A, Attuati L, et al. Radiosurgery and the prevention of regrowth of incompletely removed nonfunctioning pituitary adenomas. J Neurosurg. 2005;102(Suppl):71–74. PubMed

Pollock BE, Cochran J, Natt N, Brown PD, Erickson D, Link MJ, et al. Gamma Knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int J Radiat Oncol Biol Phys. 2008;70:1325–1329. PubMed

Pomeraniec IJ, Dallapiazza RF, Xu Z, Jane JA, Jr, Sheehan JP. Early versus late Gamma Knife radiosurgery following transsphenoidal resection for nonfunctioning pituitary macroadenomas: a matched cohort study. J Neurosurg. 2016;125:202–212. PubMed

Runge MJ, Maarouf M, Hunsche S, Kocher M, Ruge MI, El Majdoub F, et al. LINAC-radiosurgery for nonsecreting pituitary adenomas. Long-term results. Strahlenther Onkol. 2012;188:319–325. PubMed

Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg. 2002;97(5 Suppl):408–414. PubMed

Sheehan JP, Niranjan A, Sheehan JM, Jane JA, Jr, Laws ER, Kondziolka D, et al. Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg. 2005;102:678–691. PubMed

Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML. Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg. 2011;114:303–309. PubMed

Sheehan JP, Starke RM, Mathieu D, Young B, Sneed PK, Chiang VL, et al. Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J Neurosurg. 2013;119:446–456. PubMed

Snell JW, Sheehan J, Stroila M, Steiner L. Assessment of imaging studies used with radiosurgery: a volumetric algorithm and an estimation of its error. Technical note. J Neurosurg. 2006;104:157–162. PubMed

Starke RM, Nguyen JH, Rainey J, Williams BJ, Sherman JH, Savage J, et al. Gamma Knife surgery of meningiomas located in the posterior fossa: factors predictive of outcome and remission. J Neurosurg. 2011;114:1399–1409. PubMed

Starke RM, Williams BJ, Jane JA, Jr, Sheehan JP. Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism. J Neurosurg. 2012;117:129–135. PubMed

Steiner LSJ, Lindquist C, Stroila M, Steiner M. Gamma surgery in cerebral vascular lesions, malformations, tumors, and functional disorders. In: Schmidek HH, Roberts DW, editors. Schmidek & Sweet Operative Neurosurgical Techniques: Indications, Methods, and Results. 5. Vol. 1. Philadelphia: Saunders; 2006. pp. 530–576.

Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery. 1996;38:99–107. PubMed

Turner HE, Stratton IM, Byrne JV, Adams CB, Wass JA. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation—a follow-up study. Clin Endocrinol (Oxf) 1999;51:281–284. PubMed

van den Bergh AC, van den Berg G, Schoorl MA, Sluiter WJ, van der Vliet AM, Hoving EW, et al. Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys. 2007;67:863–869. PubMed

Vance ML. Pituitary adenoma: a clinician’s perspective. Endocr Pract. 2008;14:757–763. PubMed

Voges J, Kocher M, Runge M, Poggenborg J, Lehrke R, Lenartz D, et al. Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study. Cancer. 2006;107:1355–1364. PubMed

Williams BJ, Yen CP, Starke RM, Basina B, Nguyen J, Rainey J, et al. Gamma Knife surgery for parasellar meningiomas: long-term results including complications, predictive factors, and progression-free survival. J Neurosurg. 2011;114:1571–1577. PubMed

Wilson PJ, De-Loyde KJ, Williams JR, Smee RI. A single centre’s experience of stereotactic radiosurgery and radiotherapy for non-functioning pituitary adenomas with the linear accelerator (Linac) J Clin Neurosci. 2012;19:370–374. PubMed

Woollons AC, Hunn MK, Rajapakse YR, Toomath R, Hamilton DA, Conaglen JV, et al. Non-functioning pituitary adenomas: indications for postoperative radiotherapy. Clin Endocrinol (Oxf) 2000;53:713–717. PubMed

Wowra B, Stummer W. Efficacy of Gamma Knife radiosurgery for nonfunctioning pituitary adenomas: a quantitative follow up with magnetic resonance imaging-based volumetric analysis. J Neurosurg. 2002;97(5 Suppl):429–432. PubMed

Zhang X, Fei Z, Zhang J, Fu L, Zhang Z, Liu W, et al. Management of nonfunctioning pituitary adenomas with suprasellar extensions by transsphenoidal microsurgery. Surg Neurol. 1999;52:380–385. PubMed

Primary versus postoperative stereotactic radiosurgery for acromegaly: a multicenter matched cohort study